Significant differences in CVD risk factors between men and women with type 2 diabetes

May 15, 2014
©2014 Mary Ann Liebert, Inc., publishers

Type 2 diabetes greatly increases a person's risk of developing cardiovascular disease (CVD). A new study showing that cardiovascular risk factors such as elevated blood pressure and cholesterol levels differ significantly between men and women is published in Diabetes Technology & Therapeutics (DTT), a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

Joni Strom Williams, MD, MPH and coauthors from Medical University of South Carolina and Ralph H. Johnson VA Medical Center (Charleston, SC), compared three individual CVD risk factors and a "composite control" factor (comprised of all three risk factors together) among a group of men and women with type 2 diabetes. In the article "Gender Differences in Composite Control of Cardiovascular Risk Factors Among Patients with Type 2 Diabetes" the authors report significant disparities for blood pressure, low-density lipoprotein (LDL) cholesterol, and composite control, but not for control of glycosylated hemoglobin A1c.

"Cardiovascular disease continues to be a significant factor for increased morbidity and mortality in people with type 2 diabetes," says DTT Editor-in-Chief Satish Garg, MD, Professor of Medicine and Pediatrics at the University of Colorado Denver. "Every attempt should be made to reduce gender differences as they relate to co-morbidities."

Explore further: Diabetes associated with higher risk of cardiovascular problems in men

More information: The article is available free on the DTT website at http://www.liebertpub.com/dtt.

Related Stories

Interarm BP difference may up cardiac risk in diabetes

April 3, 2014

(HealthDay)—Interarm differences in systolic blood pressure (BP) in patients with diabetes may be associated with an increased risk of cardiovascular morbidity and mortality, according to research published online on March ...

Serum marker predicts cardiovascular events in diabetes

April 25, 2014

(HealthDay)—Elevated levels of polyclonal serum immunoglobulin combined free light chains (cFLCs) may indicate adverse cardiovascular disease (CVD) outcomes in patients with type 2 diabetes, according to research published ...

Recommended for you

Amyloid-related heart failure now detectable with imaging test

August 24, 2016

A type of heart failure caused by a build-up of amyloid can be accurately diagnosed and prognosticated with an imaging technique, eliminating the need for a biopsy, according to a multicenter study led by researchers at Columbia ...

Biomarkers may help better predict who will have a stroke

August 24, 2016

People with high levels of four biomarkers in the blood may be more likely to develop a stroke than people with low levels of the biomarkers, according to a study published in the August 24, 2016, online issue of Neurology, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.